BioConvergence LLC, a life sciences contract service provider, celebrated its 10th year in business on April 17th.
Bloomington, IN (April 21, 2016) – BioConvergence is pleased to announce it has reached its tenth year of operations. Starting in 2006, the company was a service provider to the pharmaceutical and biopharmaceutical sectors, and since then has expanded to the animal health, diagnostics, and medical device industries. BioConvergence is a women-owned, small business operating in a 72,000 square foot facility in Bloomington, Indiana.
The company’s service lines include drug formulation development, analytical methods development and testing activities, formulation and filling, labeling and kitting operations, and supply chain management. BioConvergence provides these services to firms of all sizes, from virtual organizations to large pharma, and to companies with needs around the globe. Over the years, the company has played important roles in the development of several products on the market today. BioConvergence focuses on innovation, flexibility, responsiveness, and building customized solutions for clients, always keeping the patient in mind.
“We made it!” Alisa Wright, founder and CEO said. “The past 10 years have been wonderful due to the privilege and trust our clients extended to us and the valuable results our team delivered to our clients. We will continue to expand our capabilities to provide the customer care and tangible value our clients depend on. Thank you to all of our clients, vendors, board members, family, and friends for all the support. We are proud to be a part of the Bloomington community.”
For more information on BioConvergence, visit www.bioc.us/ or contact BioConvergence at email@example.com